ArticleOncology letters2026

A three-gene signature correlated with MAPK/ERK activation characterizes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer.

Changtai Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.